Bio-Techne Introduces Advanced ESR1 Mutation Monitoring Assay for Breast Cancer Treatment Insights Bio-Techne's new ESR1 mutation monitoring assay offers high sensitivity for detecting mutations linked to hormone receptor-positive metastatic breast cancer.

Bio-Techne Introduces Advanced ESR1 Mutation Monitoring Assay for Breast Cancer Treatment Insights #United_States #Minneapolis #Bio-Techne #ESR1 #Asuragen